CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleRevenue is $31,000, lower than 95% of all stocks globally
- PositionOperating margin is -318493.6%, lower than 95% of its Biotechnology peers (median -38%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
595.22MUSDvs all stocks (USD)
Revenue (TTM)
31.00KUSDvs all stocks (USD)
Profit Margin
0.00%vs Biotechnology peers
Beta
0.1760xvs all stocks
52-Week Change
-19.26%vs all stocks
Market Capitalization
595.22MUSDvs all stocks (USD)
Enterprise Value
301.07MUSDvs all stocks (USD)
Forward P/E
-4.58xvs Biotechnology peers
Price to Book (MRQ)
1.26xvs Biotechnology peers
Enterprise to Revenue
9.71Kxvs Biotechnology peers
Enterprise to EBITDA
-3.05xvs Biotechnology peers
Profit Margin
0.00%vs Biotechnology peers
Return on Assets (TTM)
-17.20%vs Biotechnology peers
Return on Equity (TTM)
-28.88%vs Biotechnology peers
Revenue (TTM)
31.00KUSDvs all stocks (USD)
Revenue per Share (TTM)
0.0005USDUpdated Sep 26, 2026Gross Profit (TTM)
-66.69MUSDvs all stocks (USD)
EBITDA (TTM)
-98.63MUSDvs all stocks (USD)
Net Income (TTM)
-91.76MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-100.00%vs Biotechnology peers
Operating Cash Flow (TTM)
-76.51MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-48.79MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Biotechnology peers
Revenue
41.00KUSDFY2025 · Dec 31, 2025Operating Income
-94.49MUSDvs all stocks (USD)
Pre-tax Income
-88.77MUSDFY2025 · Dec 31, 2025Income Tax Expense
-681.00KUSDFY2025 · Dec 31, 2025Net Income
-88.09MUSDFY2025 · Dec 31, 2025EBIT
-87.14MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-87.03MUSDFY2025 · Dec 31, 2025Research & Development
66.43MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
28.10MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
7.54MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.64MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.00USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.00USDFY2025 · Dec 31, 2025Basic Shares Outstanding
88.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
88.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-88.09MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-67.66MUSDFY2025 · Dec 31, 2025Free Cash Flow
-67.67MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
43.80MUSDFY2025 · Dec 31, 2025Interest Paid
975.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-88.09MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
112.00KUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-681.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
16.08MUSDFY2025 · Dec 31, 2025Other Non-cash Items
363.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
2.06MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
2.51MUSDFY2025 · Dec 31, 2025Capital Expenditures
-11.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-285.45MUSDFY2025 · Dec 31, 2025Sale of Investments
152.99MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-132.47MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
35.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-2.22MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
206.51MUSDFY2025 · Dec 31, 2025Shares Outstanding
194.47MSharesUpdated Sep 26, 2026Float Shares
164.38MSharesUpdated Sep 26, 2026Shares Short
51.75MSharesUpdated Sep 26, 2026Short Ratio
13.51daysvs all stocks
Short % of Shares Outstanding
26.64%vs all stocks
% Held by Insiders
0.42%vs all stocks
% Held by Institutions
77.85%vs all stocks
Total Cash (MRQ)
326.28MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.68USDUpdated Sep 26, 2026Total Debt (MRQ)
36.02MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0760xvs Biotechnology peers
Current Ratio (MRQ)
26.78xvs Biotechnology peers
Book Value per Share (MRQ)
2.44USDUpdated Sep 26, 2026Total Assets
279.93MUSDvs all stocks (USD)
Total Current Assets
278.19MUSDFY2025 · Dec 31, 2025Total Liabilities
55.04MUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.74MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
40.04MUSDFY2025 · Dec 31, 2025Total Current Liabilities
15.00MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
43.76MUSDFY2025 · Dec 31, 2025Other Short-term Investments
229.70MUSDFY2025 · Dec 31, 2025Accounts Receivable
1.22MUSDFY2025 · Dec 31, 2025Accounts Payable
2.72MUSDFY2025 · Dec 31, 2025Short-term Debt
256.00KUSDFY2025 · Dec 31, 2025Long-term Debt
35.43MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
4.45MUSDFY2025 · Dec 31, 2025Common Stock (Book)
11.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-649.48MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
224.89MUSDvs all stocks (USD)
52-Week Low
2.56USDUpdated Sep 26, 202652-Week High
6.44USDUpdated Sep 26, 202652-Week Change
-19.26%vs all stocks
Beta
0.1760xvs all stocks
50-Day MA
3.08USDUpdated Sep 26, 2026200-Day MA
3.54USDUpdated Sep 26, 2026Avg 10-Day Volume
3.96MSharesUpdated Sep 26, 2026Avg 30-Day Volume
3.94MSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-0.7600USDUpdated Sep 26, 2026Other Income / Expense
-190.00KUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Is this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -318493.6%, lower than 95% of its Biotechnology peers (median -38%)Significant
Operating margin: -3,184.936Industry median: -0.38Industry P5: -43.63Peers compared: 260
Current ratio is 26.78×, higher than 95% of its Biotechnology peers (median 5.71×)Significant
Current ratio: 26.78Industry median: 5.71Industry P95: 22.21Peers compared: 260
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.68
Altman Z-Score 3.34: safe zoneNotable
Altman Z-Score: 3.34
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Revenue is $31,000, lower than 95% of all stocks globallySignificant
Revenue (USD): 31,000Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Bohui Innovation Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shenzhen Neptunus Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Valneva SE
Tier 1ProductionApproval-Gated PipelineRuleRisk
Genfit S.A.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Gkht Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jinling Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
SS Innovations International, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Wohua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Phathom Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
OrthoPediatrics Corp.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Archer Aviation Inc.
2 interpretationsHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBCLow-Leverage Liquidity Configuration
IonQ, Inc.
2 interpretationsHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBCLow-Leverage Liquidity Configuration
Procept BioRobotics Corporation
2 interpretationsHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBCLow-Leverage Liquidity Configuration